A biophysical approach to phospholipase A2 activity and inhibition by anti-inflammatory drugs

Biophysical Chemistry

Volumn 152, Issue 1-3, 2010, Pages 109-117

  Gaspar, Diana ^a   Lúcio, Marlene ^a   Wagner, Kerstin ^b   Brezesinski, Gerald ^b   Rocha, Sandra ^a   Costa Lima, J L F ^a   Reis, Salette ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

Author keywords

Enzymatic inhibition; Membrane biophysical properties; Membrane model systems; NSAIDs; SPLA2

Indexed keywords

HYDROLASE; IBUPROFEN; PHOSPHOLIPASE A2; PIROXICAM;

ARTICLE; BIOPHYSICS; BREWSTER ANGLE MICROSCOPY; CIRCULAR DICHROISM; DRUG INHIBITION; ENZYME ACTIVITY; FLUORESCENCE; LIPID BILAYER; LIPID MEMBRANE; MEMBRANE; MOLECULE; NAJA MOSSAMBICA MOSSAMBICA; PRIORITY JOURNAL; SNAKE; SPECTROSCOPY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOCATALYSIS; CATALYTIC DOMAIN; CIRCULAR DICHROISM; FLUORESCENT DYES; IBUPROFEN; LIPID BILAYERS; PHOSPHOLIPASES A2; PIROXICAM; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE;

NAJA MOSSAMBICA MOSSAMBICA;

EID: 78149284600     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2010.08.006     Document Type: Article

References (42)

1. Singh N., Jabeen T., Somvanshi R.K., Sharma S., Dey S., Singh T.P. Phospholipase A(2) as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDs): crystal structure of the complex formed between phospholipase A(2) and oxyphenbutazone at 1.6 angstrom resolution. Biochemistry 2004, 43:14577-14583.
2. Six D.A., Dennis E.A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2000, 1488:1-19.
3. Jameel N.M., Shekhar M.A., Vishwanath B.S. Alpha-lipoic acid: an inhibitor of secretory phospholipase A(2) with anti-inflammatory activity. Life Sci. 2006, 80:146-153.
4. Monti M.C., Casapullo A., Santomauro C., D'Auria M.V., Riccio R., Gomez-Paloma L. The molecular mechanism of bee venom phospholipase A(2) inactivation by bolinaquinone. Chembiochem 2006, 7:971-980.
5. Schaloske R.H., Dennis E.A. The phospholipase A(2) superfamily and its group numbering system. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2006, 1761:1246-1259.
6. Raguenes-Nicol C., Russo-Marie F., Domage G., Diab N., Solito E., Dray F., et al. Anti-inflammatory mechanism of alminoprofen: action on the phospholipid metabolism pathway. Biochem. Pharmacol. 1999, 57:433-443.
7. Yedgar S., Cohen Y., Shoseyov D. Control of phospholipase A(2) activities for the treatment of inflammatory conditions. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2006, 1761:1373-1382.
8. Kini R.M. Excitement ahead: structure, function and mechanism of snake venom phospholipase A(2) enzymes. Toxicon 2003, 42:827-840.
9. Wagner K., Desbat B., Brezesinski G. Liquid-liquid immiscibility in model membranes activates secretory phospholipase A(2). Biochim. Biophys. Acta, Biomembr. 2008, 1778:166-174.
10. Dahmen-Levison U., Brezesinski G., Mohwald H. Specific adsorption of PLA(2) at monolayers. Thin Solid Films 1998, 329:616-620.
11. Wagner K., Brezesinski G. Modifying dipalmitoylphosphatidylcholine monolayers by n-hexadecanol and dipalmitoylglycerol. Chem. Phys. Lipids 2007, 145:119-127.
12. Tatulian S.A., Biltonen R.L., Tamm L.K. Structural changes in a secretory phospholipase A(2) induced by membrane binding: a clue to interfacial activation?. J. Mol. Biol. 1997, 268:809-815.
13. Burack W.R., Gadd M.E., Biltonen R.L. Modulation of Phospholipase A(2) - identification of an inactive membrane-bound state. Biochemistry 1995, 34:14819-14828.
14. Dahmen-Levison U., Brezesinski G., Mohwald H., Jakob J., Nuhn P. Investigations of lipid-protein interactions on monolayers of chain-substituted phosphatidylcholines Angew. Chem. Int. Ed. Engl. 2000, 39:2775-2778.
15. Shimshick E.J., McConnell H.M. Lateral phase separation in phospholipid membranes. Biochemistry 1973, 12:2351-2360.
16. Franson R.C., Eisen D., Jesse R., Lanni C. Inhibition of highly purified mammalian phospholipases A2 by non-steroidal anti-inflammatory agents - modulation by calcium-ions. Biochem. J. 1980, 186:633-636.
17. Lobo I.B., Hoult J.R.S. Group-I, Group-II and Group-III extracellular phospholipases A(2) - selective-inhibition of group-II enzymes by indomethacin but not other NSAIDs. Agents Actions 1994, 41:111-113.
18. Richieri G.V., Ogata R.T., Kleinfeld A.M. The measurement of free fatty acid concentration with the fluorescent probe ADIFAB: a practical guide for the use of the ADIFAB probe. Mol. Cell Biochem. 1999, 192:87-94.
19. Richieri G.V., Ogata R.T., Kleinfeld A.M. Thermodynamics of fatty-acid-binding to fatty-acid-binding proteins and fatty-acid partition between water and membranes measured using the fluorescent-probe adifab. J. Biol. Chem. 1995, 270:15076-15084.
20. Wagner K., Brezesinski G. Phospholipase D activity is regulated by product segregation and the structure formation of phosphatidic acid within model membranes. Biophys. J. 2007, 93:2373-2383.
21. Melzer V., Weidemann G., Vollhardt D., Brezesinski G., Wagner R., Struth B., et al. Brewster angle microscopy and X-ray GID studies of morphology and crystal structure in monolayers of N-tetradecyl-gamma, delta-dihydroxypentanoic acid amide. J. Phys. Chem. B 1997, 101:4752-4758.
22. Lakowicz J.R. Principles of fluorescence spectroscopy 2006, Springer, New York.
23. Zhai X.H., Li J.B., Brezesinski G., He Q., Mohwald H., Lai L.H., et al. Direct observations of the cleavage-reaction of an L-DPPC monolayer catalyzed by phospholipase A(2) and inhibited by an indole inhibitor at the air/water interface. Chembiochem 2003, 4:299-305.
24. Jablonowska E., Bilewicz R. Interactions of ibuprofen with Langmuir monolayers of membrane lipids. Thin Solid Films 2007, 515:3962-3966.
25. Damodaran K.V., Merz K.M. A comparison of DMPC- and DLPE-based lipid bilayers. Biophys. J. 1994, 66:1076-1087.
26. Welzel P.B., Cammenga H.K. Equilibrium penetration of DMPC monolayers by sodium cholate. J. Colloid Interface Sci. 1998, 207:70-77.
27. Copeland R.A. Enzymes: a practical introduction to structure, mechanism, and data analysis 2000, Wiley-VCH.
28. Richieri G.V., Kleinfeld A.M. Continuous measurement of phospholipase A(2) activity using the fluorescent probe ADIFAB. Anal. Biochem. 1995, 229:256-263.
29. Lau S.Y.M., Taneja A.K., Hodges R.S. Synthesis of a model protein of defined secondary and quaternary structure - effect of chain length on the stabilization and formation of 2-stranded alpha-helical coiled-coils. J. Biol. Chem. 1984, 259:3253-3261.
30. Cooper T.M., Woody R.W. The effect of conformation on the CD of interacting helices: a theoretical study of tropomyosin. Biopolymers 1990, 30:657-676.
31. Arni R.K., Ward R.J. Phospholipase A(2) - a structural review. Toxicon 1996, 34:827-841.
32. Jameel N.M., Frey B.M., Frey F.J., Gowda T.V., Vishwanath B.S. Inhibition of secretory phospholipase A(2) enzyme by bilirubin: a new role as endogenous anti-inflammatory molecule. Mol. Cell Biochem. 2005, 276:219-225.
33. Lin Y.H., Huang W.N., Lee S.C., Wu W.G. Heparin reduces the alpha-helical content of cobra basic phospholipase A(2) and promotes its complex formation. Int. J. Biol. Macromol. 2000, 27:171-176.
34. Tatulian S.A. Structural effects of covalent inhibition of phospholipase A(2) suggest allosteric coupling between membrane binding and catalytic sites. Biophys. J. 2003, 84:1773-1783.
35. Zhou N.E., Kay C.M., Hodges R.S. Synthetic model proteins - positional effects of interchain hydrophobic interactions on stability of 2-stranded alpha-helical coiled-coils. J. Biol. Chem. 1992, 267:2664-2670.
36. Qin S., Pande A.H., Nemec K.N., Tatulian S.A. The N-terminal alpha-helix of pancreatic phospholipase A(2) determines productive-mode orientation of the enzyme at the membrane surface. J. Mol. Biol. 2004, 344:71-89.
37. Duysens L.N. The flattening of the absorption spectrum of suspensions, as compared to that of solutions. Biochim. Biophys. Acta 1956, 19:1-12.
38. Arnold G.E., Day L.A., Dunker A.K. Tryptophan contributions to the unusual circular-dichroism of Bacteriophage-Fd. Biochemistry 1992, 31:7948-7956.
39. Chang L.S., Kuo K.W., Chang C.C. Identification of functional involvement of tryptophan residues in Phospholipase-A(2) from Naja-naja-atra (Taiwan Cobra) snake-venom. Biochim. Biophys. Acta 1993, 1202:216-220.
40. Sumandea M., Das S., Sumandea C., Cho W. Roles of aromatic residues in high interfacial activity of Naja naja atra phospholipase A(2). Biochemistry 1999, 38:16290-16297.
41. Winget J.M., Pan Y.H., Bahnson B.J. The interfacial binding surface of phospholipase A2s. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2006, 1761:1260-1269.
42. Tatulian S.A. Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation. Biophys. J. 2001, 80:789-800.